Metformin + Vildagliptin is medically used to treat type 2 diabetes mellitus, hyperglycemia. It also used to improve insulin sensitivity and weight management.

Metformin + Vildagliptin is primarily used to manage type 2 diabetes mellitus. Specifically, it controls hyperglycemia and improves insulin sensitivity in patients with this condition.

Metformin + Vildagliptin is administered orally as tablets and is available in the strength of 50mg/500mg. The recommended starting dosage and any necessary dose adjustments are determined based on the specific condition being treated and the patient's response to the medication.

Metformin + Vildagliptin may cause several side effects, varying in severity. Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal discomfort. Additionally, individuals may experience headaches, dizziness, weakness, and a metallic taste in the mouth. More serious but rare side effects may include lactic acidosis, which can be life-threatening, and severe allergic reactions characterized by rash, itching, swelling, dizziness, and breathing difficulties.

Lactic acidosis, a rare but potentially serious condition, is risky after using Metformin + Vildagliptin. The risk of hypoglycemia increases when it is combined with other antidiabetic medications.

Seek immediate medical attention if symptoms such as muscle pain, weakness, abdominal discomfort, hyperventilation, or unusual sleepiness occur after taking Metformin + Vildagliptin. Close monitoring of blood sugar levels is crucial, especially during the initial phase of treatment.

Regularly check kidney function as Metformin + Vildagliptin is eliminated through the kidneys. Be cautious of low blood sugar levels, especially when taking other diabetes medications. Watch for symptoms of lactic acidosis and seek immediate medical help if experienced. Temporarily stop medication before using contrast agents for medical tests. Use with care in patients with liver problems and be mindful of any signs of infection. Inform healthcare providers about the medication before any surgery or medical procedures. Be aware of potential allergic reactions and report any promptly. Monitor for vitamin B12 deficiency during long-term use and consider supplementation if needed. Stay hydrated, especially during illness or in hot weather, to prevent dehydration complications. Consult a healthcare provider for any changes in management during periods of stress, like surgery or infections. Use caution during pregnancy and lactation, and discuss potential risks and benefits with a healthcare provider.

1. Pharmadox Healthcare Ltd., Electronic Medicines Compendium (EMC), [Revised on August 2023] [Accessed on 22nd Oct 2023], https://www.medicines.org.uk/emc/files/pil.14380.pdf
2. Galenicum Health, S.L, [Revised on April 2023] [Accessed on 22nd Oct 2023], https://medicinesauthority.gov.mt/file.ashx?f=0594EAF2C2622B403776FD1C302BFCBAFBF6CB6184EDD15C
3. Martha S. Nolte Kennedy, Umesh Masharani, Pancreatic Hormones & Anti-diabetic Drugs, Lange’s  Basic & Clinical Pharmacology, 14th Edition, 2018, 747-771.
4. KD Tripathi, Insulin, Oral Antidiabetic Drugs and Glucagon, Essentials of Medical Pharmacology, 8th Edition, 2019, 280-305.

The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.